{"title":"FDA批准了首个针对严重或危及生命疾病的新药申请的膳食补充剂","authors":"Huu S. Tieu, M. Loeffler","doi":"10.4236/pp.2022.1312038","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":432281,"journal":{"name":"Pharmacology & Pharmacy","volume":"143 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"FDA Approves First Dietary Supplement under New Drug Application with the Indication of Serious or Life-Threatening Illnesses\",\"authors\":\"Huu S. Tieu, M. Loeffler\",\"doi\":\"10.4236/pp.2022.1312038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":432281,\"journal\":{\"name\":\"Pharmacology & Pharmacy\",\"volume\":\"143 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacology & Pharmacy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4236/pp.2022.1312038\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology & Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4236/pp.2022.1312038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}